Recherche
-
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Vangl2 in the Dentate Network Modulates Pattern Separation and Pattern Completion
(Cell Reports. vol. 31, n° 10, pp. 107743, 2020-06-09)Article de revueLibre accès -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueLibre accès -
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
(Neurology. vol. 8, n° 4, 2021-04-26)Article de revueLibre accès -
The temporal origin of dentate granule neurons dictates their role in spatial memory
(Molecular Psychiatry, 2021-12)Article de revueLibre accès -
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety
(Neuron. vol. 109, n° 16, pp. 2604-2615.e9, 2021-08-18)Article de revueLibre accès -
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
(Revue Neurologique. vol. 177, n° 1-2, pp. 73-79, 2021-01)Article de revue -
Do isolated cognitive relapses exist? Commentary
(Multiple Sclerosis Journal. vol. 27, n° 10, pp. 1489-1490, 2021-09)Article de revueLibre accès -
Inhibition of mTOR signaling by genetic removal of p70 S6 kinase 1 increases anxiety-like behavior in mice
(Translational psychiatry. vol. 11, n° 1, 2021-03-15)Article de revueLibre accès